- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
COVID-19 vaccine likely to be available by early 2021, will take first shot if any trust deficit: Dr Harsh Vardhan
He assured the vaccine would be first made available to those who need it the most, irrespective of their paying capacity.
New Delhi: The coronavirus vaccine might be ready by the first quarter of 2021, Union Health and Family Welfare Minister Harsh Vardhan said on Sunday.
"While no date has been fixed for the vaccine launch, it may be ready by the first quarter of 2021," he said.
Harsh Vardhan also said that the government is considering emergency authorisation of Covid-19 vaccination to senior citizens and people working in high-risk settings. "This shall be done after a consensus has been reached," he added.
The National Expert Group on Vaccine Administration for Covid-19 is drawing up a detailed strategy on how to immunise the majority of the population, he said during the 'Sunday Samvad' programme where he interacted with his social media followers and answered their questions.
The Health Minister also assured that the government is taking full precautions in conducting the human trials of the vaccine.
"Issues like vaccine security, cost, equity, cold-chain requirements, production timelines, etc, are also being discussed intensely," he said. He assured the vaccine would be first made available to those who need it the most, irrespective of their paying capacity.
Harsh Vardhan also said he would be happy to take the first dosage of the vaccine if some people have a trust deficit.
His statement came in the wake of an incident in the UK where one of the participants in the ongoing trial of the University of Oxford's vaccine candidate developed a severe complication right after being administered its dose.
The Minister also informed about vaccine candidates and their development in India.
"Department of Bio-Technology (DBT), as well as the Indian Council of Medical Research (ICMR), have been pro-active in responding to the emerging situation to support the advancement of vaccine candidates. India is actively partnering with the Coalition for Epidemic Preparedness Innovations (CEPI), and trials at different phases are ongoing with respect to several vaccines in Indian laboratories (private or public) and hospitals," he said.
The minister also noted that a safe and effective vaccine will help in establishing immunity to Covid-19 at much faster pace as compared to natural infection. It is hoped that a consensus will emerge in the next few months over the desired level of protective herd immunity in any community, he said.
Read also: Potential COVID vaccine: NII study conducted on mice show positive results
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.